Adenocarcinoma of the Esophagus Completed Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01561014Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionTreatment